Search results
Results From The WOW.Com Content Network
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is a peer-reviewed medical journal covering research on diabetes, metabolic syndromes, and obesity. The journal was established in 2008 and is published by Dove Medical Press.
Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. [1]
This article provides a global overview of the current trends and distribution of metabolic syndrome. Metabolic syndrome (also known as the cardiometabolic syndrome) refers to a cluster of related risk factors for cardiovascular disease that includes abdominal obesity, diabetes, hypertension, and elevated cholesterol. [1] [2]
Some research suggests that metabolically healthy obese individuals are at an increased risk of several adverse outcomes when compared to individuals of a normal weight, including type 2 diabetes, [11] depressive symptoms, [12] and cardiovascular events.
A recent study conducted a comparative cross-sectional evaluation of baseline circulating levels of the novel hormone Irisin and the established adipokine adiponectin with metabolic syndrome, cardio-metabolic variables and cardiovascular disease risk, and they found out that the baseline irisin levels were significantly higher in subjects with ...
Initially titled "syndrome X", the constellation of symptoms is now known as the metabolic syndrome and an object of extensive scientific inquiry, especially given that the combination strongly predisposes for cardiovascular disease. Still, Reaven believes that contemporary criteria are arbitrary and that it may not be necessary to define it as ...
[7] [clarification needed] An analysis from an earlier NHANES from 1988 to 1994 found people with NWO had a four-fold higher frequency of metabolic syndrome compared with the low body fat group. [8] In 2015 the overall presence in the general worldwide population was suggested to be about 20%, with European populations having the highest rate ...
The BRI has proved effective as an index for identifying risk of death from different diseases, [3] disorders of metabolic syndrome, [4] [5] [7] liver disease, [6] cardiovascular diseases in association with sarcopenia, [8] and bone mineral density. [9]